Results 61 to 70 of about 22,506 (225)
Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury
Frontiers in Immunology, 2018 BackgroundAcute lung injury (ALI) is characterized by suppressed fibrinolytic activity in bronchoalveolar lavage fluid (BALF) attributed to elevated plasminogen activator inhibitor-1 (PAI-1).
Cong Liu +12 more
doaj +1 more source
The use of combination of fibrinolytic therapy and abciximab in the treatment of the acute myocardial infarction with ST elevation [PDF]
Vojnosanitetski Pregled, 2002 Background. According to current knowledge, the best way to treat the acute myocardial infarction with ST elevation is primary transluminal coronary angioplasty, which can be performed only in the best equipped tertiary cardiology centers.
Gligić Branko +4 more
doaj +1 more source
Haemostatic changes and bleeding with anti‐IL‐6 directed therapy in autoimmune diseases
British Journal of Pharmacology, EarlyView.Abstract Anti‐IL‐6 directed therapy, especially tocilizumab (TCZ), is widely used for the treatment of autoimmune diseases such as rheumatoid arthritis, giant cell arteritis and systemic juvenile idiopathic arthritis. Next to being a master regulator of inflammation, IL‐6 also is an important regulator of haemostasis. Although generally well tolerated,
Charlotte D. C. C. van der Heijden +3 more
wiley +1 more source
Thrombelastographic patterns produced by fibrinolytic agents incorporated in fibrin
, 1965 Lysis of clots produced from bovine fibrinogen and bovine thrombin in the presence of fibrinolytic agents was followed by thrombelastography in order to obtain information about the mechanism of clot lysis in a standardized, purified system, which ...
Tage Astrup, Klas Egeblad
core +1 more source
Incidence, predictors and prognostic implications of bleeding complicating primary percutaneous coronary intervention [PDF]
Vojnosanitetski Pregled, 2015 Background/Aim. Data about bleeding complicating primary percutaneous coronary intervention (PCI) are more frequently obtained from randomized clinical trials on patients with acute coronary syndromes (ACS), but less frequently from surveys or ...
Matić Dragan M. +10 more
doaj +1 more source
Haemophilia, EarlyView.ABSTRACT Rare bleeding disorders (RBDs) represent a diverse group of inherited conditions involving coagulation factors or platelets. These conditions, such as Glanzmann thrombasthenia (GT) or severe coagulation factor deficiencies, are uncommon. In contrast, bleeding disorder of unknown cause (BDUC) is a diagnosis of exclusion without an identifiable ...
Alessandro Casini +4 more
wiley +1 more source
, 1986 Twenty-six patients presenting with 28 instances of massive acute thrombotic obstruction of a prosthetic valve (16 mitral, 12 aortic) were treated with fibrinolytic agents.
Ohayon, Jöel P. +5 more
core +1 more source
Perioperative Outcomes in Factor XI Deficiency: A Systematic Review
Haemophilia, EarlyView.ABSTRACT Background Congenital factor XI (FXI) deficiency has a variable bleeding phenotype, and FXI activity alone does not predict perioperative bleeding. Management practices remain heterogeneous, and available evidence derives from case reports, small case series, and retrospective cohorts.
Zainab Al‐Housni +6 more
wiley +1 more source
, 1983 The reproducibility, precision and required conditions of the fibrin plate method for determination of fibrinolytic agents are described in detail. Under optimal conditions the assay is a sensitive and precise method for the quantitative determination of
Astrup, T., Jespersen, J.; id_orcid
core +1 more source
A Study of Coagulation-fibrinolysis System and Fibrinolytic Enzyme Therapy in Surgical Vascular Disease [PDF]
, 1973 A study on coagulation-fibrinolysis system in surgical vascular disease was made to search for genesis of thrombosis and its therapy. Special consideration was taken into the availability of fibrinolytic enzyme for thrombosis. The results obtained in the
Mitsuyasu OZAKI, Ozaki, Mitsuyasu
core +1 more source